Impact of different emulsifiers on biocompatibility and inflammatory potential of Perfluorohexyloctane (F6H8) emulsions for new intravenous drug delivery systems

References

• Agarwal P, Scherer D, Gunther B, Rupenthal ID. Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs. Int J Pharm. 2018;538(1–2):119–129. doi:10.1016/j.ijpharm.2018.01.01929339249
   PubMed Web of Science ®Google Scholar
• De Majumdar S, Subinya M, Korward J, Pettigrew A, Scherer D, Xu H. A low concentration of tacrolimus/semifluorinated alkane (SFA) eyedrop suppresses intraocular inflammation in experimental models of uveitis. Curr Mol Med. 2017;17(3):211–220.28782485
   PubMed Web of Science ®Google Scholar
• Tsagogiorgas C, Jung T, Krebs J, et al. Aerosolized semifluorinated alkanes as excipients are suitable for inhalative drug delivery – a pilot study. Int J Pharm. 2012;422(1–2):194–201.22079720
   PubMed Web of Science ®Google Scholar
• Tsagogiorgas C, Theisinger S, Heesch E, et al. Evaluation of pharmacokinetic properties and anaesthetic effects of propofol in a new perfluorohexyloctane (F6H8) emulsion in rats – a comparative study. Int J Pharm. 2015;486(1–2):69–76.25797054
   PubMed Web of Science ®Google Scholar
• Krafft MP, Riess JG. Highly fluorinated amphiphiles and colloidal systems, and their applications in the biomedical field. A contribution. Biochimie. 1998;80(5–6):489–514.9782389
   PubMed Web of Science ®Google Scholar
• Krafft MP, Riess JG. Chemistry, physical chemistry, and uses of molecular fluorocarbon–hydrocarbon diblocks, triblocks, and related compounds – unique “apolar” components for self-assembled colloid and interface engineering. Chem Rev. 2009;109(5):1714–1792.19296687
   PubMed Web of Science ®Google Scholar
• Meinert H, Knoblich A. The use of semifluorinated alkanes in blood-substitutes. Biomater Artif Cells Immobilization Biotechnol. 1993;21(5):583–595.8117848
   PubMed Web of Science ®Google Scholar
• Lehmler HJ. Perfluorocarbon compounds as vehicles for pulmonary drug delivery. Expert Opin Drug Deliv. 2007;4(3):247–262.17489652
   PubMed Web of Science ®Google Scholar
• Li X, Sui Z, Li X, et al. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery. Int J Nanomedicine. 2018;13:3053–3067.29872293
   PubMed Web of Science ®Google Scholar
• Riess JG. Perfluorocarbon-based oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol. 2006;34(6):567–580. doi:10.1080/1073119060097382417090429
   PubMed Web of Science ®Google Scholar
• Krafft MP, Chittofrati A, Riess JG. Emulsions and microemulsions with a fluorocarbon phase. Curr Opin Colloid Interface Sci. 2003;8(3):251–258. doi:10.1016/S1359-0294(03)00045-1
   Web of Science ®Google Scholar
• Riess JG. Oxygen carriers (“blood substitutes”) – raison d’etre, chemistry, and some physiology. Chem Rev. 2001;101(9):2797–2920.11749396
   PubMed Web of Science ®Google Scholar
• Meinert H, Roy T. Semifluorinated alkanes – a new class of compounds with outstanding properties for use in ophthalmology. Eur J Ophthalmol. 2000;10(3):189–197. doi:10.1177/112067210001000301
   Web of Science ®Google Scholar
• Seiffge DJ, Lapina NE, Tsagogiorgas C, Theisinger B, Henning RH, Schilling L. Improvement of oxygen supply by an artificial carrier in combination with normobaric oxygenation decreases the volume of tissue hypoxia and tissue damage from transient focal cerebral ischemia. Exp Neurol. 2012;237(1):18–25. doi:10.1016/j.expneurol.2012.06.00722728375
   PubMed Web of Science ®Google Scholar
• Flaim SF. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(4):1043–1054. doi:10.3109/107311994091388017849908
   PubMed Web of Science ®Google Scholar
• Ingram DA, Forman MB, Murray JJ. Activation of complement by Fluosol attributable to the pluronic detergent micelle structure. J Cardiovasc Pharmacol. 1993;22(3):456–461.7504138
   PubMed Web of Science ®Google Scholar
• Schoof E, von der Hardt K, Kandler MA, et al. Aerosolized perfluorocarbon reduces adhesion molecule gene expression and neutrophil sequestration in acute respiratory distress. Eur J Pharmacol. 2002;457(2–3):195–200.12464366
   PubMed Web of Science ®Google Scholar
• Gale SC, Gorman GD, Copeland JG, McDonagh PF. Perflubron emulsion prevents PMN activation and improves myocardial functional recovery after cold ischemia and reperfusion. J Surg Res. 2007;138(1):135–140.17173933
   PubMed Web of Science ®Google Scholar
• Haeberle HA, Nesti F, Dieterich HJ, Gatalica Z, Garofalo RP. Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation. Am J Respir Crit Care Med. 2002;165(10):1433–1438.12016108
   PubMed Web of Science ®Google Scholar
• Burkhardt W, Koehne P, Wissel H, et al. Intratracheal perfluorocarbons diminish LPS-induced increase in systemic TNF-alpha. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1043–L1048.18359887
   PubMed Web of Science ®Google Scholar
• Gue E, Since M, Ropars S, Herbinet R, Le Pluart L, Malzert-Freon A. Evaluation of the versatile character of a nanoemulsion formulation. Int J Pharm. 2016;498(1–2):49–65.26685727
   PubMed Web of Science ®Google Scholar
• Fuss IJ, Kanof ME, Smith PD, Zola H. Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol. 2009 ;Chapter 7:Unit7.1.
   PubMedGoogle Scholar
• Wang W. Tolerability of hypertonic injectables. Int J Pharm. 2015;490(1–2):308–315.26027488
   PubMed Web of Science ®Google Scholar
• Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102.16303268
   PubMed Web of Science ®Google Scholar
• Carrstensen H, Muller RH, Muller BW. Particle size, surface hydrophobicity and interaction with serum of parenteral fat emulsions and model drug carriers as parameters related to RES uptake. Clin Nutr. 1992;11(5):289–297.16840011
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Murray JC. Poloxamer-188 revisited: a potentially valuable immune modulator. J Natl Cancer Inst. 1996;88(11):766–768.8637036
   PubMedGoogle Scholar
• Moghimi SM, Hedeman H, Christy NM, Illum L, Davis SS. Enhanced hepatic clearance of intravenously administered sterically stabilized microspheres in zymosan-stimulated rats. J Leukoc Biol. 1993;54(6):513–517.8245702
   PubMed Web of Science ®Google Scholar
• Ingram DA, Forman MB, Murray JJ. Phagocytic activation of human neutrophils by the detergent component of fluosol. Am J Pathol. 1992;140(5):1081–1087.1316083
   PubMed Web of Science ®Google Scholar
• Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood. 2008;112(4):935–945.18684880
   PubMed Web of Science ®Google Scholar
• Dinkelmann S, Rohlke W, Meinert H, Northoff H. A system establishment compatibility profiles for artificial oxygen carriers and other substances. Artif Cells Blood Substit Immobil Biotechnol. 2001;29(1):57–70.11280685
   PubMed Web of Science ®Google Scholar
• Edwards CM, Lowe KC, Rohlke W, Geister U, Reuter P, Meinert H. Effects of a novel perfluorocarbon emulsion on neutrophil chemiluminescence in human whole blood in vitro. Artif Cells Blood Substit Immobil Biotechnol. 1997;25(3):255–260.9167840
   PubMed Web of Science ®Google Scholar
• Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol. 2005;33(1):47–63.15768565
   PubMed Web of Science ®Google Scholar
• Tsagogiorgas C, Theisinger S, Holm P, Thiel M, Quintel M, Holm R. Buccal absorption of propofol when dosed in 1-perfluorobutylpentane to anaesthetised and conscious Wistar rats and Gottingen mini-pigs. Eur J Pharm Biopharm. 2013;85(3Pt B):1310–1316.23851078
   PubMed Web of Science ®Google Scholar
• Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 1994;84(5):1415–1420.8068938
   PubMed Web of Science ®Google Scholar
• Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995;184(1):39–51.7622868
   PubMed Web of Science ®Google Scholar
• Crowley LC, Marfell BJ, Scott AP, Waterhouse NJ. Quantitation of apoptosis and necrosis by Annexin V binding, propidium iodide uptake, and flow cytometry. Cold Spring Harb Protoc. 2016;2016:11.
   Google Scholar
• De Jaeghere F, Allemann E, Feijen J, Kissel T, Doelker E, Gurny R. Cellular uptake of PEO surface-modified nanoparticles: evaluation of nanoparticles made of PLA:PEO diblock and triblock copolymers. J Drug Target. 2000;8(3):143–153.10938524
   PubMed Web of Science ®Google Scholar
• Jaulin N, Appel M, Passirani C, Barratt G, Labarre D. Reduction of the uptake by a macrophagic cell line of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate). J Drug Target. 2000;8(3):165–172.10938526
   PubMed Web of Science ®Google Scholar
• Sahay G, Batrakova EV, Kabanov AV. Different internalization pathways of polymeric micelles and unimers and their effects on vesicular transport. Bioconjug Chem. 2008;19(10):2023–2029.18729494
   PubMed Web of Science ®Google Scholar
• Setti C, Suarato G, Perotto G, Athanassiou A, Bayer IS. Investigation of in vitro hydrophilic and hydrophobic dual drug release from polymeric films produced by sodium alginate-MaterBi(R) drying emulsions. Eur J Pharm Biopharm. 2018;130:71–82.29928979
   PubMed Web of Science ®Google Scholar
• Heard SO, Puyana JC. The anti-inflammatory effects of perfluorocarbons: let’s get physical. Crit Care Med. 2000;28(4):1241–1242.10809324
   PubMed Web of Science ®Google Scholar
• Smith TM, Steinhorn DM, Thusu K, Fuhrman BP, Dandona P. A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit Care Med. 1995;23(9):1533–1539.7664556
   PubMed Web of Science ®Google Scholar
• Nath KA, Balla G, Vercellotti GM, et al. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest. 1992;90(1):267–270.1634613
   PubMed Web of Science ®Google Scholar
• Shimizu H, Takahashi T, Suzuki T, et al. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med. 2000;28(3):809–817.10752834
   PubMed Web of Science ®Google Scholar
• Agarwal A, Bolisetty S. Adaptive responses to tissue injury: role of heme oxygenase-1. Trans Am Clin Climatol Assoc. 2013;124:111–122.23874015
   PubMedGoogle Scholar
• Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 2006;70(3):432–443.16775600
   PubMed Web of Science ®Google Scholar
• Ge ZJ, Jiang GJ, Zhao YP, Wang GX, Tan YF. Systemic perfluorohexane attenuates lung injury induced by lipopolysaccharide in rats: the role of heme oxygenase-1. Pharmacol Rep. 2010;62(1):170–177.20360627
   PubMed Web of Science ®Google Scholar
• Maluf DG, Mas VR, Yanek K, et al. Molecular markers in stored kidneys using perfluorocarbon-based preservation solution: preliminary results. Transplant Proc. 2006;38(5):1243–1246.16797273
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int. 2004;66(2):480–485.15253693
   PubMed Web of Science ®Google Scholar
• Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. 2004;66(2):486–491.15253694
   PubMed Web of Science ®Google Scholar
• Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm. 2009;2009:137072.20182538
   PubMed Web of Science ®Google Scholar
• Burne-Taney MJ, Rabb H. The role of adhesion molecules and T cells in ischemic renal injury. Curr Opin Nephrol Hypertens. 2003;12(1):85–90.12496671
   PubMed Web of Science ®Google Scholar
• Fontana J, Vogt A, Hohenstein A, et al. Impact of steroids on the inflammatory response after ischemic acute kidney injury in rats. Indian J Nephrol. 2017;27(5):365–371.28904432
   PubMedGoogle Scholar
• Steven P, Augustin AJ, Geerling G, et al. Semifluorinated alkane eye drops for treatment of dry eye disease due to meibomian gland disease. J Ocul Pharmacol Ther. 2017;33(9):678–685.28922088
   PubMed Web of Science ®Google Scholar